Author

K. Ozawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:rat· 2 Research Focus:cell signaling & trafficking· 1 Organism:mouse· 1

Frequent Co-Authors

A. Kitazaki· 1 shared E. Kobayashi· 1 shared K. Matsui· 1 shared K. Matsumoto· 1 shared K. Morimoto· 1 shared M. Yoshii· 1 shared N. Koda· 1 shared N. Matsumoto· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Kitazaki

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fetal Kidney Transplantation for In Utero Fetuses

K. Morimoto, S. Yamanaka, K. Matsui, Y. Kinoshita, Y. Inage, S. Yamamoto, N. Koda, N. Matsumoto, Y. Saito, T. Takamura, T. Fujimoto, S. Fukunaga, S. Tajiri, K. Matsumoto, K. Ozawa, , T. Yokoo

This paper describes a novel fetal therapy approach using transplanted fetal kidneys from different species to provide a bridge to dialysis in affected fetuses, demonstrating successful urine production and long-term function without immunosuppressants.

bioRxiv · Apr 15, 2024 · PreprintBioengineering

Effects of Simvastatin on RBL-2H3 cell degranulation.

M. Yoshii, A. Kitazaki, K. Ozawa

This study shows simvastatin inhibits RBL-2H3 cell degranulation by blocking downstream signaling pathways, with effects reversed by geranylgeraniol.

bioRxiv · Sep 25, 2022Pharmacology & Toxicology